RIPK3 and malignant colon neoplasm: Nonetheless, the study of Jing et al. sheds light on the controversial role of RIPK3 in different malignant lesions: in colon cancer, the lack of RIPK3 causes the activation of the NF-kB pathway, inducing increased levels of IL-6 and tumor progression [167].